Adding tirzepatide to basal insulin cuts HbA1c levels in people with poorly controlled type 2 diabetes
A team of medical researchers affiliated with multiple institutions in the U.S. working with a colleague from Spain has found via clinical trial that adding tirzepatide (brand name Mounjaro) to basal insulin therapies can ...